Published in Contraception on June 13, 2007
Contraception technology: past, present and future. Contraception (2012) 1.06
Vaginally administered PEGylated LIF antagonist blocked embryo implantation and eliminated non-target effects on bone in mice. PLoS One (2011) 0.85
Effect of sexual intercourse on the absorption of levonorgestrel after vaginal administration of 0.75 mg in Carraguard gel: a randomized, cross-over, pharmacokinetic study. Contraception (2008) 0.77
Timing of sexual intercourse in relation to ovulation. Effects on the probability of conception, survival of the pregnancy, and sex of the baby. N Engl J Med (1995) 6.16
Pituitary-ovarian function following the standard levonorgestrel emergency contraceptive dose or a single 0.75-mg dose given on the days preceding ovulation. Contraception (2004) 2.99
Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial. Lancet (2002) 2.86
Why consider vaginal drug administration? Fertil Steril (2004) 2.54
Experimental gonococcal genital tract infection and opacity protein expression in estradiol-treated mice. Infect Immun (1999) 1.86
Preliminary safety and acceptability of a carrageenan gel for possible use as a vaginal microbicide. Sex Transm Infect (2000) 1.54
Pentosan polysulfate, a sulfated oligosaccharide, is a potent and selective anti-HIV agent in vitro. Antiviral Res (1988) 1.47
Comparison of microbicides for efficacy in protecting mice against vaginal challenge with herpes simplex virus type 2, cytotoxicity, antibacterial properties, and sperm immobilization. Sex Transm Dis (2001) 1.43
Sulfated polysaccharides inhibit lymphocyte-to-epithelial transmission of human immunodeficiency virus-1. Biol Reprod (1996) 1.42
Vaginal formulations of carrageenan protect mice from herpes simplex virus infection. Clin Diagn Lab Immunol (1997) 1.36
Colposcopic evaluation of a vaginal gel formulation of iota-carrageenan. Contraception (1997) 1.33
Safety and acceptability of the candidate microbicide Carraguard in Thai Women: findings from a Phase II Clinical Trial. J Acquir Immune Defic Syndr (2006) 1.30
Inhibition of Neisseria gonorrhoeae genital tract infection by leading-candidate topical microbicides in a mouse model. J Infect Dis (2004) 1.18
Emergency contraception: why can't you give it away? Qualitative findings from an evaluation of advance provision of emergency contraception. Contraception (2004) 0.98
Does meloxicam increase the incidence of anovulation induced by single administration of levonorgestrel in emergency contraception? A pilot study. Hum Reprod (2006) 0.95
Pharmacokinetic study of different dosing regimens of levonorgestrel for emergency contraception in healthy women. Hum Reprod (2002) 0.92
The first uterine pass effect. Ann N Y Acad Sci (1997) 0.91
Comparison of uterine concentrations of ethinyl estradiol and etonogestrel after use of a contraceptive vaginal ring and an oral contraceptive. Fertil Steril (2006) 0.89
Pharmacokinetics and endometrial tissue levels of levonorgestrel after administration of a single 1.5-mg dose by the oral and vaginal route. Fertil Steril (2005) 0.89
Pharmacokinetics of levonorgestrel 0.75 mg tablets. Contraception (2002) 0.88
Blood levels of levonorgestrel in women following vaginal placement of contraceptive pills. Fertil Steril (1983) 0.85
Emergency contraceptive pill (ECP) and sexual risk behaviour. Int J STD AIDS (2002) 0.85
The pharmacokinetics of 750 microg levonorgestrel following administration of one single dose or two doses at 12- or 24-h interval. Contraception (2001) 0.84
Pharmacokinetic study to compare the absorption and tolerability of two doses of levonorgestrel following single vaginal administration of levonorgestrel in Carraguard gel: a new formulation for "dual protection" contraception. Contraception (2007) 0.84
Bioavailability of the Yuzpe and levonorgestrel regimens of emergency contraception: vaginal vs. oral administration. Contraception (2005) 0.79
Family planning: the unfinished agenda. Lancet (2006) 8.65
Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial. Lancet (2008) 7.93
Caesarean delivery rates and pregnancy outcomes: the 2005 WHO global survey on maternal and perinatal health in Latin America. Lancet (2006) 6.56
Maternal and neonatal individual risks and benefits associated with caesarean delivery: multicentre prospective study. BMJ (2007) 4.92
Hyperdominance in the Amazonian tree flora. Science (2013) 2.98
Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans. Pain (2008) 2.91
Extracellular signal-regulated kinase phosphorylates tumor necrosis factor alpha-converting enzyme at threonine 735: a potential role in regulated shedding. Mol Biol Cell (2002) 2.54
Meta-analysis of 200 or 600 mg mifepristone in association with two prostaglandins for termination of early pregnancy. Contraception (2009) 2.44
Methodological considerations in implementing the WHO Global Survey for Monitoring Maternal and Perinatal Health. Bull World Health Organ (2008) 2.15
Epidemiological study of child & adolescent psychiatric disorders in urban & rural areas of Bangalore, India. Indian J Med Res (2005) 2.15
Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism. J Fam Plann Reprod Health Care (2013) 2.07
Thrombophilic risk factors are uncommon in young patients with retinal vein occlusion. Retina (2015) 2.04
Maternal near miss and maternal death in the World Health Organization's 2005 global survey on maternal and perinatal health. Bull World Health Organ (2009) 1.90
Erk5 participates in neuregulin signal transduction and is constitutively active in breast cancer cells overexpressing ErbB2. Mol Cell Biol (2002) 1.64
Insights into the historical construction of species-rich Mesoamerican seasonally dry tropical forests: the diversification of Bursera (Burseraceae, Sapindales). New Phytol (2011) 1.61
Intervention to reduce catheter-related bloodstream infections in a pediatric intensive care unit. Intensive Care Med (2011) 1.58
Intracluster correlation coefficients from the 2005 WHO Global Survey on Maternal and Perinatal Health: implications for implementation research. Paediatr Perinat Epidemiol (2008) 1.56
An alternative echocardiographic method to estimate mean pulmonary artery pressure: diagnostic and clinical implications. J Am Soc Echocardiogr (2009) 1.54
Determining the feasibility of utilizing the microbicide applicator compliance assay for use in clinical trials. Contraception (2007) 1.46
Hormonal contraception and the risk of HIV acquisition among women in South Africa. AIDS (2012) 1.41
Development of the Post Cardiac Surgery (POCAS) prognostic score. Crit Care (2013) 1.40
Retrospective evaluation of the effectiveness of epsilon aminocaproic acid for the prevention of postamputation bleeding in retired racing Greyhounds with appendicular bone tumors: 46 cases (2003-2008). J Vet Emerg Crit Care (San Antonio) (2012) 1.37
Genome of multidrug-resistant uropathogenic Escherichia coli strain NA114 from India. J Bacteriol (2011) 1.33
Population-based incidence of type 2 diabetes in northern Spain: the Asturias Study. Diabetes Care (2007) 1.32
Pain from copper intrauterine device insertion: randomized trial of prophylactic ibuprofen. Am J Obstet Gynecol (2006) 1.25
Neuregulin expression modulates clinical response to trastuzumab in patients with metastatic breast cancer. J Clin Oncol (2007) 1.16
Identifying the most suitable endogenous control for determining gene expression in hearts from organ donors. BMC Mol Biol (2007) 1.13
The effect of the proteasome inhibitor bortezomib on acute myeloid leukemia cells and drug resistance associated with the CD34+ immature phenotype. Haematologica (2008) 1.13
Up-regulation of PPARγ, heat shock protein-27 and -72 by naringin attenuates insulin resistance, β-cell dysfunction, hepatic steatosis and kidney damage in a rat model of type 2 diabetes. Br J Nutr (2011) 1.13
Aplidin, a marine organism-derived compound with potent antimyeloma activity in vitro and in vivo. Cancer Res (2008) 1.11
Genome of a novel isolate of Paracoccus denitrificans capable of degrading N,N-dimethylformamide. J Bacteriol (2011) 1.08
Effect of multikinase inhibitors on caspase-independent cell death and DNA damage in HER2-overexpressing breast cancer cells. J Natl Cancer Inst (2010) 1.07
Understanding the factors associated with differences in caesarean section rates at hospital level: the case of Latin America. Paediatr Perinat Epidemiol (2009) 1.06
Determinants of the rate and extent of spermatogenic suppression during hormonal male contraception: an integrated analysis. J Clin Endocrinol Metab (2008) 1.05
Contraceptive vaginal rings: a review. Contraception (2010) 1.04
Long-term administration of mifepristone (RU486): clinical tolerance during extended treatment of meningioma. Cancer Invest (2006) 1.03
Infection of human fallopian tube epithelial cells with Neisseria gonorrhoeae protects cells from tumor necrosis factor alpha-induced apoptosis. Infect Immun (2006) 1.03
Time trends in minimum mortality temperatures in Castile-La Mancha (Central Spain): 1975-2003. Int J Biometeorol (2007) 1.02
New strategies for providing hormonal contraception in developing countries. Contraception (2010) 1.00
Maternal melatonin selectively inhibits cortisol production in the primate fetal adrenal gland. J Physiol (2003) 0.99
Progesterone receptors: a key for neuroprotection in experimental stroke. Endocrinology (2012) 0.99
Genomes of two chronological isolates (Helicobacter pylori 2017 and 2018) of the West African Helicobacter pylori strain 908 obtained from a single patient. J Bacteriol (2011) 0.99
Primary malignant melanoma at unusual sites: an institutional experience with review of literature. Melanoma Res (2010) 0.98
Preventing copper intrauterine device removals due to side effects among first-time users: randomized trial to study the effect of prophylactic ibuprofen. Hum Reprod (2006) 0.98
Cyclical mastalgia and breast cancer risk: results of a French cohort study. Cancer Epidemiol Biomarkers Prev (2006) 0.97
Characterization and optimization of AMG 517 supersaturatable self-emulsifying drug delivery system (S-SEDDS) for improved oral absorption. J Pharm Sci (2009) 0.97
Genome sequence and comparative pathogenomics analysis of a Salmonella enterica Serovar Typhi strain associated with a typhoid carrier in Malaysia. J Bacteriol (2012) 0.96
Genetic fine structure of a Salmonella enterica serovar Typhi strain associated with the 2005 outbreak of typhoid fever in Kelantan, Malaysia. J Bacteriol (2012) 0.95
Clinically relevant progestins regulate neurogenic and neuroprotective responses in vitro and in vivo. Endocrinology (2010) 0.95
Progesterone and Nestorone facilitate axon remyelination: a role for progesterone receptors. Endocrinology (2011) 0.94
Molecular pathways: P-Rex in cancer. Clin Cancer Res (2013) 0.94
The neural androgen receptor: a therapeutic target for myelin repair in chronic demyelination. Brain (2013) 0.93
A new combination of testosterone and nestorone transdermal gels for male hormonal contraception. J Clin Endocrinol Metab (2012) 0.93
Combined transdermal testosterone gel and the progestin nestorone suppresses serum gonadotropins in men. J Clin Endocrinol Metab (2009) 0.93
A clinical trial of 7 alpha-methyl-19-nortestosterone implants for possible use as a long-acting contraceptive for men. J Clin Endocrinol Metab (2003) 0.93
Pharmacokinetic study of different dosing regimens of levonorgestrel for emergency contraception in healthy women. Hum Reprod (2002) 0.92
Progesterone and progestins: neuroprotection and myelin repair. Curr Opin Pharmacol (2008) 0.90
Erk5 is activated and acts as a survival factor in mitosis. Cell Signal (2007) 0.89
Feasibility study of Nestorone-ethinylestradiol vaginal contraceptive ring for emergency contraception. Contraception (2005) 0.89
Management of patients receiving long-term treatment with mifepristone. Fertil Steril (2005) 0.88
Retrospective study of pulmonary function tests in patients presenting with isolated reduction in single-breath diffusion capacity: implications for the diagnosis of combined obstructive and restrictive lung disease. Mayo Clin Proc (2007) 0.88
Comparative actions of progesterone, medroxyprogesterone acetate, drospirenone and nestorone on breast cancer cell migration and invasion. BMC Cancer (2008) 0.87
Neosaxitoxin as a local anesthetic: preliminary observations from a first human trial. Anesthesiology (2007) 0.87
Ulipristal blocks ovulation by inhibiting progesterone receptor-dependent pathways intrinsic to the ovary. Reprod Sci (2012) 0.86
10th Summit Meeting consensus: recommendations for regulatory approval for hormonal male contraception. J Androl (2006) 0.86
Effects of a novel estrogen-free, progesterone receptor modulator contraceptive vaginal ring on inhibition of ovulation, bleeding patterns and endometrium in normal women. Contraception (2011) 0.86
Contraceptive vaginal rings releasing Nestorone and ethinylestradiol: a 1-year dose-finding trial. Contraception (2005) 0.86
Curve of amniotic fluid index measurements in low-risk pregnancy. Acta Obstet Gynecol Scand (2007) 0.85
Transition from Norplant to Jadelle in a clinic with extensive experience providing contraceptive implants. Contraception (2006) 0.84
Pharmacokinetic study to compare the absorption and tolerability of two doses of levonorgestrel following single vaginal administration of levonorgestrel in Carraguard gel: a new formulation for "dual protection" contraception. Contraception (2007) 0.84
Effects of levonorgestrel-releasing IUS and progesterone receptor modulator PRM CDB-2914 on uterine leiomyomas. Contraception (2007) 0.84
Perinatal neuroendocrine regulation. Development of the circadian time-keeping system. Mol Cell Endocrinol (2002) 0.83
Flexible thermoplastic denture base materials for aesthetical removable partial denture framework. J Clin Diagn Res (2013) 0.83
Progesterone receptor modulator CDB-2914 induces extracellular matrix metalloproteinase inducer in cultured human uterine leiomyoma cells. Mol Hum Reprod (2008) 0.83
Evaluating the clinical safety of three vaginal applicators: a pilot study conducted in the Dominican Republic. Contraception (2005) 0.83
Effect of chlorhexidine cavity disinfection on microleakage in cavities restored with composite using a self-etching single bottle adhesive. J Conserv Dent (2011) 0.82
Nestorone: clinical applications for contraception and HRT. Steroids (2003) 0.82
Progesterone receptor modulator CDB-2914 down-regulates proliferative cell nuclear antigen and Bcl-2 protein expression and up-regulates caspase-3 and poly(adenosine 5'-diphosphate-ribose) polymerase expression in cultured human uterine leiomyoma cells. J Clin Endocrinol Metab (2004) 0.82
Mechanical complications during central venous cannulations in pediatric patients. Intensive Care Med (2009) 0.82
Mesothelial/monocytic incidental cardiac excrescences (MICE) with tubercular aortitis: report of the first case with brief review of the literature. J Clin Pathol (2010) 0.82